Found 1565 chains in Genus chains table. Displaying 1 - 50. Applied filters: Proteins

Search results query: Pkinase_Tyr

Total Genus Sequence Length pdb Title
87 294 6rfiA Irak4 in complex with inhibitor
92 291 6in0A Crystal structure of epha3 in complex with 18-crown-6
91 299 6iupA Crystal structure of fgfr4 kinase domain in complex with compound 5
88 289 6nvhA Fgfr4 complex with n-(2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)-3-methylphenyl)acrylamide
85 289 6nviA Fgfr4 complex with n-(3-chloro-2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)-5-fluorophenyl)acrylamide
83 303 6nvlA Fgfr1 complex with n-(2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)-3-methylphenyl)acrylamide
86 290 6nvjA Fgfr4 complex with n-(2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)-3-fluorophenyl)acrylamide
81 289 6nvkA Fgfr4 complex with blu-554, n-((3s,4s)-3-((6-(2,6-dichloro-3,5-dimethoxyphenyl)quinazolin-2-yl)amino)tetrahydro-2h-pyran-4-yl)acrylamide
85 290 6nvgA Fgfr4 complex with n-(3,5-dichloro-2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)phenyl)acrylamide
99 307 6mweA Crystal structure of tie2 in complex with decipera compound dp1919
89 306 6hmxA Rip2 kinase catalytic domain complex with n(4,5dimethyl1hpyrazol3yl)7methoxy6(2methylpropane2sulfonyl)quinolin4amine
89 271 6hm7A Crystal structure of spleen tyrosine kinase (syk) in complex with a 2-(phenoxymethyl)pyridine inhibitor
81 270 6mibA Crystal structure of the ilk atp-binding deficient mutant (l207w)/alpha-parvin core complex
86 269 6hm6A Crystal structure of spleen tyrosine kinase (syk) in complex with a 2-(pyridinyloxymethyl)pyridine inhibitor
90 288 6hd4A Abl1 in complex with compound 7 and imatinib (sti-571)
90 301 6elrA Human jak1 kinase domain in complex with compound 7
86 287 6dudA Jak3 with cyanamide cp12
92 303 6finA Ddr1, 3-[(3-cyclopropyl-1,2,4-oxadiazol-5-yl)methyl]-8-(1h-indazole-5-carbonyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one, 1.670a, p1211, rfree=22.8%
87 287 6db4A Jak3 with cyanamide cp34
86 299 6ferA Crystal structure of human ddr2 kinase in complex with 2-[4,5-difluoro-2-oxo-1'-(1h-pyrazolo[3,4-b]pyridine-5-carbonyl)spiro[indole-3,4'-piperidine]-1-yl]-n-(2,2,2-trifluoroethyl)acetamide
94 303 6fimA Ddr1, 2-[8-(1h-indazole-5-carbonyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-3-yl]-n-methylacetamide, 1.440a, p1211, rfree=24.1%
84 285 6da4A Jak3 with cyanamide cp10
95 307 6fiqA Ddr1, 1-(1h-indazole-5-carbonyl)-5'-methoxy-1'-[2-oxo-2-[(2s)-2-(trifluoromethyl)pyrrolidin-1-yl]ethyl]spiro[piperidine-4,3'-pyrrolo[3,2-b]pyridine]-2'-one, 1.790a, p212121, rfree=23.8%
93 301 6fexA Ddr1, 2-[4-bromo-2-oxo-1'-(1h-pyrazolo[4,3-b]pyridine-5-carbonyl)spiro[indole-3,4'-piperidine]-1-yl]-n-(2,2,2-trifluoroethyl)acetamide, 1.291a, p212121, rfree=17.4%
91 271 6di1A Crystal structure of btk in complex with covalent fragment ligand
95 303 6filA Ddr1, 2-[8-(1h-indazole-5-carbonyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-3-yl]-n-methylacetamide, 1.730a, p212121, rfree=24.5%
84 287 6db3A Jak3 with cyanamide cp23
94 303 6fewA Ddr1, 2-[8-(1h-indazole-5-carbonyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-3-yl]-n-methylacetamide, 1.440a, p1211, rfree=24.1%
92 271 6di0A Crystal structure of btk in complex with fragment ligand
99 309 6fioA Ddr1, 2-[1'-(1h-indazole-5-carbonyl)-4-methyl-2-oxospiro[indole-3,4'-piperidine]-1-yl]-n-(2,2,2-trifluoroethyl)acetamide, 1.990a, p6522, rfree=27.7%
88 266 6bkwA Btk complex with compound 12
87 263 6bkhA Btk complex with compound 11
87 264 6blnA Btk complex with compound 13
92 309 6bsdA Ddr1 bound to dasatinib
86 264 6bikA Btk complex with compound 7
82 264 6bkeA Btk complex with compound 10
91 309 6brjA Ddr1 bound to vx-680
88 269 6npeA C-abl kinase domain with the activator(cmpd6), 2-cyano-n-(4-(3,4-dichlorophenyl)thiazol-2-yl)acetamide
88 269 6npvA C-abl kinase domain with the activator(cmpd51), n-(1-(3,4-dichlorophenyl)-4-(2-hydroxyethyl)-4,5-dihydro-1h-pyrazol-3-yl)isonicotinamide
86 269 6npuA C-abl kinase domain with the activator(cmpd29), n-(1-(3,4-dichlorophenyl)-4,5-dihydro-1h-pyrazol-3-yl)acetamide
100 302 5qinA Tgf-beta receptor type 2 kinase domain in complex with n- {4-[3-(6-methoxypyridin-3-yl)-1h-pyrrolo[3,2-b]pyridin-2- yl]pyridin-2-yl}acetamide
89 271 6n9pA Discovery of affinity-based probes for btk occupancy assay
79 268 6nfiA Btk in complex with inhibitor n-(3-{[(2,6-dimethylphenyl)methyl]amino}-7-methoxyindeno[1,2-c]pyrazol-6-yl)methanesulfonamide
90 271 6nfhA Btk in complex with inhibitor 8-(2,3-dihydro-1h-inden-5-yl)-2-({4-[(2s)-3-(dimethylamino)-2-hydroxypropoxy]phenyl}amino)-5,8-dihydropteridine-6,7-dione
77 262 6mnyA Crystal structure of mouse btk kinase domain in complex with compound 9a
83 302 6mzwA Tas-120 covalent complex with fgfr1
100 296 6n8gA Irak4 bound to benzoxazole compound
96 328 6il3A Crystal structure of the flt3 kinase bound to a small molecule inhibitor
94 307 6mx8A Crystal structure of anaplastic lymphoma kinase (alk) bound by brigatinib
85 302 6mzqA Tas-120 in reversible binding mode with fgfr1